Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Boehringer collaborates with biotech firm to detect global disease outbreaks
Lifebit's REAL platform will monitor and interpret scientific publications and other open sources to identify infectious disease outbreaks.

Project will combine real-world evidence with AI to track transboundary infections.

Boehringer Ingelheim has announced a multi-year partnership with biotech firm Lifebit to detect and report global disease outbreaks. 

Through the partnership, scientists will work collaboratively to combine real-world evidence and the latest AI algorithms to identify diseases, particularly those that cross borders, and respond accordingly. 

Lifebit's REAL platform analyses data harvested from millions of tweets, news articles and scientific publications to notify users of relevant disease outbreaks, such as COVID-19. 

As well as speeding up the detection of the latest outbreaks, researchers hope the insights will enable Boehringer’s research and development efforts to be prioritised accordingly.

“External innovation is becoming an increasingly important aspect of our R&D playbook. Therefore, we are strategically partnering with Lifebit to leverage AI to monitor and interpret scientific and other sources in real-time, enabling us to track data related to animal diseases,” commented Dr Eric Haaksma, head of animal health global innovation at Boehringer Ingelheim.

“This, in turn, will accelerate the detection process as the vast amounts of scientific relevant information being produced at many levels cannot be feasibly collected and analysed manually.”

Lifebit CEO Dr Maria Chatzou-Dunford added: “At Lifebit, we thrive at connecting both, locked-up sensitive biomedical data from around the world and AI-driven automated RWE data insights – so that companies at the cutting edge of science, like Boehringer Ingelheim, can make faster and smarter decisions – delivering insights that change lives.”

Become a member or log in to add this story to your CPD history

VetCT app offered to students and new graduates

News Story 1
 The VetCT app is being offered for free to students and new veterinary graduates for their first three months in practice. The app provides a service for vets to send case information to a global team of Diploma-holding specialists, who can provide advice and support via instant call-back, text chat, written report, or virtual appointment.

Time on the app is automatically logged as CPD with quarterly certificates being generated for users. Additional services include the ability to book bespoke CPD, significant event reviews, and live training sessions such as surgical procedures.

The app is downloadable for both iOS and Android systems. 

Click here for more...
News Shorts
HORIBA to host CPD webinar

HORIBA has announced that it will host an online CPD meeting focusing on 'Exotic Parasites - The Importance of Testing in The Imported Dog'. Ian Wright (BVMS, MSc, MRCVS), head of ESCCAP UK and Ireland, will present on the importance of testing protocols in diseases of imported dogs.

The meeting will provide attendees with an overview of emerging veterinary diseases with a particular focus on exotic parasites, and discuss the importance of accurate testing protocols and equipment, alongside a final Q&A session.

The webinar will take place on Thursday July 1, from 19.30pm to 21.00pm BST. For free registration and more information visit the Horiba website or register.gotowebinar.com